ETF Managers Group, LLC I Bio, Inc. Transaction History

ETF Managers Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.23 - $0.46 $638 - $1,276	2,775 Added 4.19%	68,926 $19,000
Q1 2022 May 13, 2022	BUY	$0.3 - $0.61 $79 - $162	266 Added 0.4%	66,151 $29,000
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $5,790 - $10,949	-10,528 Reduced 13.78%	65,885 $38,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $12,885 - $18,477	12,156 Added 18.92%	76,413 $81,000
Q2 2021 Aug 16, 2021	SELL	$1.22 - $1.65 $2,410 - $3,260	-1,976 Reduced 2.98%	64,257 $96,000
Q1 2021 May 17, 2021	SELL	$1.18 - $2.62 $26,364 - $58,538	-22,343 Reduced 25.22%	66,233 $99,000
Q4 2020 Feb 16, 2021	SELL	$1.05 - $2.24 $9,791 - $20,888	-9,325 Reduced 9.52%	88,576 $97,000
Q3 2020 Nov 16, 2020	BUY	$1.7 - $6.41 $100,310 - $378,228	59,006 Added 151.71%	97,901 $205,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $2.46 $33,838 - $95,681	38,895 New	38,895 $96,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.